The Europe Digital Pathology Market size was worth USD 49.86 million in 2020 and estimated to be growing at a CAGR of 10%, to reach USD 80.64 million by 2025.
Digital pathology is defined as an image-based information environment for the management, analysis, and interpretation of the information achieved from a digital slide. In short, the digitalization of conventional pathology labs is referred to as digital pathology. This technology has gained momentum in the medical and healthcare industry, owing to the improvements it brings in several applications such as drug discoveries and their development, multi-functionalities in instruments, diagnostic tests, and other research applications.
Increasing no. of cancer cases, the growing presence of teleconsultations, high efficacy of digital pathology systems with increased adoption rate and more initiatives undertook by the government as well as private companies are helping the cause of the digital pathology market. According to the World Health Organization, in 2018, Europe accounted for around 23.4% of global cases in Europe and deaths are 20.3%, which is estimated to favour the European digital pathology market as it can boost the cancer diagnosis fast. U.S. Food & Drug Administration approves the first digital pathology platform. It led to the rapid expansion of pathology tools with the application of digital pathology medicine.
On the other hand, barriers such as strict regulatory concerns for primary diagnosis, lack of standard guidelines for digital pathology, the nonexistence of reimbursement and deficiency in skilled personnel are some of the significant factors that are constraining the market in all likelihood.
However, the mounting requirement for sophisticated healthcare facilities which can be met through establishing digital pathology systems would offer lucrative opportunities for the service providers in the future if they can overcome threats like the high cost of installing new technology or building new infrastructure.
This research report segmented and sub-segmented into the following categories:
Regionally, Europe accounts for the second-largest share in the global digital pathology market following the North American market. Primarily, the development is concentrated around western countries of the region where technological advancements can counter the temporary restraints resulting in a well-prospered market. Germany is the leading market in this geography with a significant share in the forecast period.
German digital pathology market
Germany is the third-largest market of healthcare devices worldwide. In Germany, there are particular guidelines of the professional Association of German Pathologists. It focuses on IT experts, Pathologist as well as a researcher about digital pathology to diagnosis. Germany owes not only digital pathology but also the conventional pathology treatments for market growth. The IBM Corporation provides network services for the absolute result and identifies the disease's pattern & store that information and this information helps the researcher to innovate the new drug in the market. Germany government provide funding for healthcare policies to healthcare devices.
Inspirata, Inc. acquired the digital pathology company Omnyx. The company delivered the primary diagnosis in Canada & Europe. This digital pathology improves cancer diagnostic. Omnyx is a software company. It provides software to the pathology department around the world. Ibex Medical Analytics and Medipath engage the strategic partnership with the usage of artificial intelligence. The Medipath is the largest network private pathology in France.it empowers the accurate diagnosis. Alverno Laboratories have fully implemented the digital pathology in clinical laboratories. Alverno laboratories network will use Phillips Intellisite Pathology solution.
Top companies in the market are Perkin Elmer, Inc., Definiens AG, Sectra AB, Koninklijke Philips N.V., GE Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd., Hamamatsu Photonics K.K., Digipath Co., ZEISS, Olympus Corporation, Yokogawa Electronics Corporation and Quorum Technologies Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Type
5.1.1 Human Digital Pathology
5.1.2 Animal Digital Pathology
5.2 By Product
5.2.1 Scanners
5.2.2 Software
5.2.3 Communication Systems
5.2.4 Storage Systems
5.3 By Application
5.3.1 Teleconsultation
5.3.2 Disease Diagnosis
5.3.3 Drug Discovery
5.3.4 Training and Education
5.4 By End User
5.4.1 Pharmaceutical Companies
5.4.2 Hospitals
5.4.3 Academic Institutes
6.1 Introduction
6.2 U.K
6.3 France
6.4 Germany
6.5 Italy
6.6 Spain
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1. Perkin Elmer, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2. Definiens AG
8.3. Sectra AB
8.4. Koninklijke Philips N.V
8.5. GE Healthcare
8.6. Inspirata Co.
8.7. Ventana Medical Systems, Inc.
8.8. Leica Biosystems
8.9. 3D-Histech Ltd
8.10. Hamamatsu Photonics, K.K.
8.11. Digipath Co.
8.12. ZEISS
8.13. Olympus Corporation
8.14. Yokogawa Electronic Corporation
8.15. Quorum Technologies Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
